Stay updated on HER2+ Breast Cancer Adjuvant Trial

Sign up to get notified when there's something new on the HER2+ Breast Cancer Adjuvant Trial page.
Latest website image capture
Clouds background image

Latest updates to the HER2+ Breast Cancer Adjuvant Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The record now presents the BOLD-1 Phase III breast cancer trial, including its treatment arms, eligibility criteria, outcomes, and study status. It also includes study locations, investigators, and record dates.
    Difference
    45%
    Check dated 2026-11-08T06:41:01.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T09:27:30.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A notice appears above the ClinicalTrials.gov page announcing NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T07:24:49.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T06:40:55.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T08:20:44.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page, replacing the study details with a generic error layout and site footer. This means the study record is not accessible at this time.
    Difference
    18%
    Check dated 2026-09-20T04:35:25.000Z thumbnail image

Stay in the know with updates to HER2+ Breast Cancer Adjuvant Trial

Enter your email address, and we'll notify you when there's something new on the HER2+ Breast Cancer Adjuvant Trial page.